Yizhou Zhang
P.R. China
Shenyang, 110004, China
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Micro-vascularized Multicellular Pancreatic Ductal Adenocarcinoma (PDAC) spheroid: A novel 3D PDAC Research Model.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: May 29, 2026
Sirp-α Antibody Inhibits Renal Cell Carcinoma Progression via Akt1/Akt2 Modulation in Tumor-Associated Macrophages.
Journal: Journal of inflammation research
Published: March 27, 2025
Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Journal: Cancer cell international
Published: February 12, 2023
Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Journal: Frontiers in immunology
Published: July 02, 2022
Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer.
Journal: Frontiers in immunology
Published: July 01, 2022
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
Journal: Frontiers in immunology
Published: May 23, 2022
Normalization of tumor vasculature: A potential strategy to increase the efficiency of immune checkpoint blockades in cancers.
Journal: International immunopharmacology
Published: May 16, 2022
HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
Journal: International journal of oncology
Published: March 22, 2022
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Journal: Journal of advanced research
Published: March 05, 2022
Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways.
Journal: Frontiers in cell and developmental biology
Published: October 17, 2021
Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 26, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026